Cosgrove Sara E, Patel Alpa, Song Xiaoyan, Miller Robert E, Speck Kathleen, Banowetz Amy, Hadler Rachel, Sinkowitz-Cochran Ronda L, Cardo Denise M, Srinivasan Arjun
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Infect Control Hosp Epidemiol. 2007 Jun;28(6):641-6. doi: 10.1086/518345. Epub 2007 May 10.
To evaluate (1) the framework of the 12 Steps to Prevent Antimicrobial Resistance Among Hospitalized Adults that is part of the Centers for Disease Control and Prevention (CDC) Campaign to Prevent Antimicrobial Resistance in Healthcare Settings, with regard to steps addressing antimicrobial use; and (2) methods of feedback to clinicians regarding antimicrobial use after postprescription review.
Prospective intervention to identify and modify inappropriate antimicrobial therapy.
A 1,000-bed, tertiary care teaching hospital.
Inpatients in selected medicine and surgery units receiving broad-spectrum antimicrobials for 48-72 hours.
We created a computer-based clinical-event detection system that automatically identified inpatients taking broad-spectrum and "reserve" antimicrobials for 48-72 hours. Although prior approval was required for initial administration of broad-spectrum and reserve antimicrobials, once approval was obtained, therapy with the antimicrobials could be continued indefinitely at the discretion of the treating clinician. Therapy that was ongoing at 48-72 hours was reviewed by an infectious diseases pharmacist or physician, and when indicated feedback was provided to clinicians to modify or discontinue therapy. Feedback was provided via a direct telephone call, a note on the front of the medical record, or text message sent to the clinician's pager. The acceptance rate of feedback was recorded and recommendations were categorized according to the 12 steps recommended by the CDC.
Interventions were recommended for 334 (30%) of 1,104 courses of antimicrobial therapy reviewed. A total of 87% of interventions fit into one of the CDC's 12 steps of prevention: 39% into step 3 ("target the pathogen"), 1% into step 4 ("access experts"), 3% into steps 7 and 8 ("treat infection, not colonization or contamination"), 18% into step 9 ("say ;no' to vancomycin"), and 26% into step 10 ("stop treatment when no infection"). The rate of compliance with recommendations to improve antimicrobial use was 72%. No differences in compliance were seen with the different methods of feedback.
Nearly one-third of antimicrobial courses did not follow the CDC's recommended 12 steps for prevention of antimicrobial resistance. Clinicians demonstrated high compliance with following suggestions made after postprescription review, suggesting that it is a useful approach to decreasing and improving antimicrobial use among inpatients.
评估(1)作为美国疾病控制与预防中心(CDC)医疗保健机构预防抗菌药物耐药性运动一部分的《预防住院成人抗菌药物耐药性的12个步骤》框架中关于抗菌药物使用的步骤;(2)在处方后审查后向临床医生提供抗菌药物使用反馈的方法。
识别并修改不适当抗菌治疗的前瞻性干预措施。
一家拥有1000张床位的三级医疗教学医院。
选定的内科和外科病房中接受广谱抗菌药物治疗48 - 72小时的住院患者。
我们创建了一个基于计算机的临床事件检测系统,该系统能自动识别接受广谱和“储备”抗菌药物治疗48 - 72小时的住院患者。虽然广谱和储备抗菌药物的初始给药需要事先批准,但一旦获得批准,治疗医生可自行决定无限期继续使用这些抗菌药物。在48 - 72小时时正在进行的治疗由感染病药剂师或医生进行审查,并在需要时向临床医生提供反馈以修改或停止治疗。反馈通过直接电话、病历首页的便条或发送到临床医生寻呼机的短信提供。记录反馈的接受率,并根据CDC推荐的12个步骤对建议进行分类。
在审查的1104个抗菌治疗疗程中,有334个(30%)被建议进行干预。总共87%的干预措施符合CDC预防的12个步骤之一:39%符合步骤3(“针对病原体”),1%符合步骤4(“咨询专家”),3%符合步骤7和8(“治疗感染,而非定植或污染”),18%符合步骤9(“对万古霉素说‘不’”),26%符合步骤10(“无感染时停止治疗”)。改善抗菌药物使用建议的依从率为72%。不同反馈方法的依从性没有差异。
近三分之一的抗菌治疗疗程未遵循CDC推荐的预防抗菌药物耐药性的12个步骤。临床医生对处方后审查后提出的建议表现出较高的依从性,这表明这是减少和改善住院患者抗菌药物使用的一种有用方法。